Searchable abstracts of presentations at key conferences in endocrinology

ea0067o25 | Oral Presentations | EYES2019

Evaluation of microRNA in patients with obesity: association with coronary artery disease

Shvangiradze Teona A , Bondarenko Irina Z , Troshina Ekatreina A

Introduction: Recent studies claim that microRNAs (miRNAs) participate in the pathogenesis of coronary artery disease (CAD).Objective: To study miRNA expression in patients with obesity, determine their association with CAD.Methods: MiRNAs were detected in peripheral blood. 66 patients with BMI 30.0–39.9 kg/m2 were divided into 3 groups: 1st – with CAD and T2DM, 2nd – with T2DM and excluded CAD, 3rd –...

ea0063p937 | Diabetes, Obesity and Metabolism 3 | ECE2019

MicroRNA-26a, microRNA-33a, and microRNA-33b in patients with obesity: association with coronary artery disease

Shvangiradze Teona , Bondarenko Irina , Troshina Ekaterina , Karpukhin Aleksandr

Introduction: Obesity and type 2 diabetes mellitus (T2DM) are commonly associated with coronary artery disease (CAD). Recent studies demonstrated that microRNAs (miRNAs) are involved in the pathogenesis of CAD.Aim: To study miRNA-26a, microRNA-33a and microRNA-33b expression in patients with obesity.Methods: MiRNAs were detected in peripheral blood samples of 66 patients, aged 48–65 years. Patients with BMI 30.0–39.9 kg/m...

ea0049ep659 | Obesity | ECE2017

MicroRNAs, associated with coronary heart disease in patients with obesity and diabetes mellitus type 2

Shvangiradze Teona , Bondarenko Irina , Troshina Ekaterina , Shestakova Marina

Introduction: Obesity and diabetes mellitus type 2 (T2DM) are considered as one of the major risk factor for coronary heart disease (CHD) development, but the mechanisms beyond this relationship still need to be clarified. miRNAs are supposed to be involved in regulatory mechanisms in this relationship.Aim: To determine miRNAs expression in patients with obesity and T2DM.Methods: MiRNAs were detected in peripheral blood of 43 patie...

ea0049ep685 | Obesity | ECE2017

Association of Transforming growth factor β and Fibroblast growth factor 21 with cardiovascular diseases in obese patients

Shvangiradze Teona , Troshina Ekaterina , Bondarenko Irina , Shestakova Marina , Nikankina Larisa

Introduction: Obesity and type 2 diabetes mellitus (T2DM) are associated with cardiovascular diseases (CVD). Fibrotic changes in obesity include several molecular processes, including activation of Transforming growth factor β (TGF-β). Recent data indicate the involvement of Fibroblast growth factor 21 (FGF-21) as an important metabolic regulator, and even biomarker of metabolic changes in obesity and T2DM.Aim: To determine TGF-β and FGF-2...

ea0037ep553 | Obesity and cardiovascular endocrinology | ECE2015

The functional parameters of renin-angiotensin-aldosterone system in obese patients

Platonova Nadezhda , Mazurina Natalya , Shvangiradze Teona , Troshina Ekaterina , Katzia Gulnara

Introduction: Renin-angiotensin-aldosterone system (RAAS) plays a significant role in the development of arterial hypertension (AH) in obese patient. Angiotensinogen expression in adipose tissue decreases during fasting and increases in case of overeating, that leads to changes in blood pressure (BP). The aim of the study was to assess the impact of obesity on the activity of RAAS and its role in the development of hypertension.Methods: 60 women, mean ag...